CSPG4 and neoplasm: Their ability to upregulate antigens such as CSPG4 and NKG2DL addresses the critical challenge of low antigen density in solid tumors, while their compatibility with combinational strategies offers hope for overcoming tumor heterogeneity (Table 3).